SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-084615
Filing Date
2024-08-01
Accepted
2024-08-01 07:00:47
Documents
15
Period of Report
2024-07-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2420570d1_8k.htm   iXBRL 8-K 40103
2 EXHIBIT 99.1 tm2420570d1_ex99-1.htm EX-99.1 17558
6 GRAPHIC tm2420570d1_ex99-1img01.jpg GRAPHIC 9484
  Complete submission text file 0001104659-24-084615.txt   255779

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pasg-20240726.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pasg-20240726_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pasg-20240726_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2420570d1_8k_htm.xml XML 3826
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 241164156
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)